Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1/2 3Phase 3 2Phase 1 2Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 158Keratosis, Actinic 75Lymphoma, T-Cell, Cutaneous 36Skin Neoplasms 27Mycosis Fungoides 27Lymphoma, Non-Hodgkin 25Lymphoma, Mantle-Cell 25Lymphoma, Large-Cell, Immunoblastic 25Lymphoma, Large B-Cell, Diffuse 25Lymphoma, Follicular 25Leukemia, Lymphocytic, Chronic, B-Cell 25Hodgkin Disease 25Sezary Syndrome 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, B-Cell, Marginal Zone 24Burkitt Lymphoma 24Neoplasms 22Carcinoma, Basal Cell 22Neoplasm Metastasis 20Multiple Myeloma 20Leukemia, Myeloid, Chronic-Phase 20Leukemia, Myeloid, Accelerated Phase 20Leukemia, Hairy Cell 20Leukemia, Myeloid, Acute 19Blast Crisis 19Primary Myelofibrosis 18Lymphoma 18Uveal Melanoma 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Large-Cell, Anaplastic 17

Interventions

relatlimab 1pembrolizumab 1lifileucel 1Vitamin D 1Temozolomide 1Paclitaxel 1Opdualag 1Nivolumab 1Ipilimumab 1Dacarbazine 1Cholecalciferol 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Melanoma, Cutaneous Malignant × Dermatologic × Clear all
NCT06743126 2026-05-29

SUPRAME

Immatics US, Inc.

Phase 3 Recruiting
360 enrolled
Dermatologic

Melanoma, Cutaneous Malignant

NCT01748448 2025-02-17

ViDMe

Universitaire Ziekenhuizen KU Leuven

Phase 3 Completed
436 enrolled 16 charts
Dermatologic

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡